Product image of Nevirapine Lp Accord (Nevirapine) supplied by GNH India

Nevirapine Lp Accord

Active Ingredient:
Nevirapine
Origin:
EU

Nevirapine Lp Accord (Nevirapine)

Nevirapine, the active ingredient in Nevirapine Lp Accord, is a non‑nucleoside reverse transcriptase inhibitor presented as an oral formulation for oral use. It is employed in the treatment of HIV‑1 infection in adults and children as part of combination antiretroviral therapy.

GNH India supplies Nevirapine Lp Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides full regulatory documentation for export to multiple regions, ensuring timely delivery and compliance with local import requirements.

Manufacturer / TM Owner

Accord Healthcare France Sas

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nevirapine is used in antiretroviral regimens targeting HIV‑1 replication.

  • HIV‑1 infection in adults: reduces viral load as part of combination therapy.
  • HIV‑1 infection in children: contributes to viral suppression when combined with other antiretrovirals.
  • Prevention of mother‑to‑child transmission of HIV: used with other agents to lower the risk of vertical transmission.

How It Works

  • Nevirapine binds to a non‑nucleoside site on the HIV‑1 reverse transcriptase enzyme, inducing a conformational change that impairs the enzyme’s ability to transcribe viral RNA into DNA. This inhibition blocks the synthesis of proviral DNA, preventing viral replication within infected cells and thereby reducing plasma HIV‑1 RNA levels. The drug’s long half‑life allows once‑daily dosing in many treatment protocols, and its activity complements nucleoside reverse transcriptase inhibitors.

Side Effects

Nevirapine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Rash: mild to moderate skin eruptions.
  • Nausea: transient gastrointestinal discomfort.
  • Headache: mild cranial pain.
  • Fatigue: general tiredness.
  • Abdominal pain: mild stomach discomfort.
  • Dizziness: occasional light‑headedness.

Serious or Rare Side Effects

  • Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention.
  • Hepatotoxicity: elevated liver enzymes or liver failure.
  • Severe hypersensitivity: fever, malaise, and systemic rash.
  • Hepatic necrosis: rare but life‑threatening liver injury.
  • Anemia: significant drop in red blood cell count.

Precautions & Warnings

When prescribing Nevirapine, clinicians should observe several safety considerations.

  • Liver function monitoring: assess baseline and periodic hepatic enzymes.
  • Hepatitis B/C co‑infection: evaluate risk of severe liver injury.
  • Pregnancy and breastfeeding: weigh benefits against potential fetal or infant risks.
  • Drug resistance: avoid monotherapy and ensure adherence to combination regimens.
  • Concomitant CYP3A4 inducers: adjust therapy as they may lower nevirapine levels.
  • Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Avoid Interactions

Nevirapine interacts with several medicines that can alter its plasma concentrations or increase toxicity.

Major Interactions (Avoid)

  • Rifampicin: strong CYP3A4 inducer that markedly reduces nevirapine exposure.
  • Carbamazepine: enzyme inducer leading to sub‑therapeutic levels.
  • St. John’s wort: herbal inducer that may decrease efficacy.

Moderate Interactions (Monitor Closely)

  • Protease inhibitors (e.g., ritonavir): can increase nevirapine concentrations and risk hepatotoxicity.
  • Azole antifungals (e.g., ketoconazole): may raise nevirapine levels.
  • Oral contraceptives: nevirapine may reduce hormonal efficacy.
  • Warfarin: potential alteration of anticoagulant effect.

Frequently Asked Questions

Nevirapine Lp Accord contains the antiretroviral agent nevirapine and is used as part of combination therapy to treat HIV‑1 infection in adults and children. It helps lower viral load and supports immune recovery when administered with other approved HIV medicines.

Nevirapine binds to a non‑nucleoside site on the HIV‑1 reverse transcriptase enzyme, causing a conformational change that blocks the enzyme’s ability to copy viral RNA into DNA. This inhibition prevents the formation of new viral particles and reduces the amount of virus circulating in the bloodstream.

The dosing regimen for nevirapine is individualized by the prescribing clinician based on current treatment guidelines, patient weight, age, and co‑medications. Healthcare providers determine the appropriate dose and schedule, and patients should follow the prescriber’s instructions exactly.

Nevirapine can be used during pregnancy when the benefits outweigh potential risks, but data on fetal safety are limited. Breastfeeding while on nevirapine is generally discouraged because the drug is excreted in breast milk. Clinicians should evaluate each case and discuss alternatives when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and the necessary import documentation.

Nevirapine and efavirenz belong to the same drug class but differ in pharmacokinetics and side‑effect profiles. Nevirapine has a longer half‑life and is often dosed once daily after a lead‑in period, whereas efavirenz may cause more central nervous system effects. Choice of agent depends on patient tolerance, resistance patterns and co‑existing conditions.

Nevirapine Lp Accord should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

The medication is taken orally, usually with food or a light snack to reduce gastrointestinal irritation. Tablets (or the appropriate oral form) should be swallowed whole with water and taken exactly as prescribed, without crushing or chewing unless directed by a healthcare professional.

The most severe adverse events include Stevens‑Johnson syndrome or toxic epidermal necrolysis, which are life‑threatening skin reactions, and hepatotoxicity that can progress to liver failure. Prompt medical evaluation is required if patients develop rash, fever, jaundice, or unexplained fatigue.

Nevirapine is contraindicated in patients with a known hypersensitivity to the drug or any component of the formulation. It should also be avoided in individuals with severe hepatic impairment or active liver disease, and in patients who have previously experienced severe skin reactions to nevirapine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.